tigens in genetically predisposed individuals eventually determining progression to disease. Molecular mimicry between viral and self antigens could, in some instances, initiate autoimmunity. Local elicitation of inflammatory cytokines following infection probably plays a pivotal role in determining loss of functional tolerance to self autoantigens and the destructive activation of autoreactive cells. We also describe the potential role of interleukin 10, a powerful B-cell activator, in increasing the efficiency of epitope recognition, that could well be crucial to the progression toward disease. Humoral and cellular autoimmunity to islet antigens has been detected both in new-onset diabetic patients and in their first degree relatives (3-6) and in animal models of this disease (7, 8) . In particular, immune responsiveness to each of several individual islet constituents, such as glutamic acid decarboxylase (GAD), has been linked repeatedly to type I diabetes. Two research teams (9, 10) of antigens since most self-responsive lymphocytes are eliminated within the thymus. Additionally, the organism has the ability to counterregulate such destructive processes in the periphery through feedback within intricate cytokine networks. However, in some small subset of genetically predisposed individuals these "stop gap" measures of the body fail, allowing the effectors generated to destroy self.
Organ-Specific Autoimmunity

Viruses as Triggers of Autoimmunity
The question of what determines the initial loss of tolerance to a self antigen still remains to be answered. We favor the theory that infection can act as a trigger of organ-specific autoimmunity in predisposed individuals. An interesting example of the association between a viral infection and autoimmunity is offered by subacute thyroiditis, a disease whose clinical presentation in humans strongly suggests a viral pathogenesis (17) . Although subacute thyroiditis is not an autoimmune disease, these patients have autoantibodies and T-cell reactivity to thyroid autoantigens (18, 19) . These autoimmune phenomena are transient, and most of the patients recover completely. But, a few of these individuals progress from subacute thyroiditis to autoimmune thyroid disease (20) (21) (22) .
The clinical history of subacute thyroiditis may represent a general paradigm of organspecific autoimmunity with autoimmune disease following viral infections in only a subset of patients. A potential role ofviruses and other infectious agents as inducers of autoimmunity is also suggested by the association of chronic infections such as malaria, tuberculosis, syphilis, and schistosomiasis with autoimmune phenomena (23) . However, the loss of tolerance to self antigens in these patients does not usually lead to autoimmune disease, suggesting that other factors must participate.
The main difficulty in assigning a pathogenic role to any virus in type I diabetes is that during the long prodromal phase preAbbreviations: GAD, glutamic acid decarboxylase; NOD, nonobese diabetic; IFN-,y, interferon y. (24) . Interestingly, several other endocrine diseases (25) (26) (27) , thought to be autoimmune, can also develop following congenital rubella infection. Autoantibodies to tissue-specific antigens have been identified in the sera of patients with rubella-associated endocrine disease, suggesting their autoimmune pathogenesis (28, 29) .
Several years after intrauterine infection, type I diabetes was diagnosed in patients expressing the HLA class II DR3 or DR4 haplotypes (30); these haplotypes also confer an increased risk of developing type I diabetes when rubella is not involved (31) . Because congenital rubella infection can directly induce immunologic abnormalities (32), rubella-associated autoimmunity may result. However, this pathogenic mechanism would not explain why a dysfunction so induced would cause organ-specific rather than systemic autoimmunity.
An alternative hypothesis is that an initial immune response directed to rubella virus-infected cells could activate reactivity not only to the viral antigens but also to self antigens on the cells. The presence of particular HLA class I or class II molecules could affect the ability of antigen presenting cells to present self peptides specific for the target tissue. This, in turn, would determine the efficiency of an immune response to these autoantigens, a response that presumably could destroy the target tissue. Compelling data for this "mimicry" mechanism as a potential explanation for multiple sclerosis (33) has recently been presented. T-cell clones to the immunodominant myelin basic protein were activated by a variety ofviral and bacterial peptides. Interestingly, alignment of the primary amino acid sequences did not indicate the potential for activation in most of the cases. This work elegantly establishes the fact that molecular mimicry may be an underappreciated mechanism for activation of subsets of T cells that can mediate autoimmune tissue destruction (34 antigens of the infected tissue. We have investigated, in particular, the role of cytokines secreted within target tissues in determining the loss of tolerance to self antigens. The expression of interferon ry (IFN--y) in islet cells of transgenic mice led to destruction of the cells and development of type I diabetes (35) . Local expression of IFN-,y in the islets abolished tolerance to islet cell antigens in a specific manner, since the IFN-y transgenic mice rejected histocompatible islet grafts but not pituitary transplants. Loss of tolerance to self antigens can, therefore, occur not only as a result of a systemic immune defect but also as a result of local cytokine secretion. While the vast majority of self reactive, high-affinity T cells are destroyed in the thymus, some loweraffinity clones escape selection. Indeed, under normal conditions, these autoreactive cells reside in a quiescent state in the periphery (36) . Possibly, the induction of costimulatory signals by local secretion of cytokines could activate these otherwise quiescent T cells. Our theory of this process is that, following viral infection and local cytokine secretion, immune reactivity undergoes dysregulation in specific target tissues of genetically predisposed individuals. In this manner, a relatively common viral infection with tropism for a given tissue could produce organ-specific autoimmune disease in some individuals.
Regional factors within tissues are also clearly an important factor. IFN-,y is a Thl-promoting cytokine that activates T cells but no detectable humoral response to islet antigens (37) . However, the expression of IFN--y in the motor end plate led to development of antibodies to motor end plates and a disease clinically similar to human myasthenia gravis (38) . Therefore, this factor induces a distinct response pathway in different target tissues. The importance of tissue-specific factors in the induction of autoimmunity has been stressed by Barrett and coworkers (39) . These authors expressed H/K ATPase 13 subunit, an autoantigen in thymectomyinduced autoimmune gastritis of BALB/c mouse. Three days after undergoing thymectomies, the transgenic mice they used developed autoimmune gastritis and periinsulitis but not diabetes. The induction of insulitis in this model was antigen specific and absolutely dependent on the T-cell response to the transgene product in the islets. Lack of diabetes in the presence of periinsulitis strongly suggests that tissue-specific factors determine the pathogenicity of a local immune response. The inducibility of an autoimmune response could be critically affected by a localized feature, making the target cells more visible for the activated immune system. Results from a recent study (40) showed the hyperinducibility of class II molecules in thyrocytes obtained from patients with Graves disease and cultured in the presence of IFN-y.
Autoimmunity and Diversity
The search for target antigens in insulindependent diabetes mellitus has identified a large and increasing number of pancreatic islet molecules. The anti-islet response that causes diabetes is diverse from the point of T cells as well, with no T-cell receptor predominating the islet reactive repertoire. Thus, significant diversification occurs and is probably essential for enough damage for clinical disease to develop. This notion is supported by the fact that induction of immune sensitization by immunization to any of these islet antigens individually does not lead to diabetes. Thus, from the initial "insult" there is a gradual recognition of increasing numbers of islet antigens and recruitment of more islet reactive T-cell specificities into the pancreas. Evidence for the inter-and intramolecular spreading process in insulin-dependent diabetes mellitus has been presented recently (9, 10) . The molecular processes governing determinant spreading in insulin-dependent diabetes mellitus are of significant interest, since they allow a unique axis for intervention. B lymphocytes may be critical for this diversification process since they have the unique capability to concentrate proteins and present nondominant determinants to T lymphocytes. A role for B lymphocytes in the development of autoimmune diabetes in the NOD mouse was demonstrated by experiments where B lymphocytes were abrogated by anti-IgM administration (41) . Factors that regulate activation of B lymphocytes and enhancement of their antigen presenting ability may be very important in the disease process (42) . Interestingly, the cytokine interleukin 10 is a potent B-cell activator and enhances major histocompatibility complex II expression on B cells. We have found that this cytokine accelerates disease when overexpressed in the pancreatic islets (43) and it has also been found that it is essential for disease to progress (M. S. Lee, R. Mueller, L. S. Wicker, L. B. Peterson, and N.S., unpublished data). We now hypothesize that this molecule is important in the diversification process that precedes disease. A further understanding of cytokine regulation of diversification, processing enzymes and antigen presenting cells involved will be an important area of upcoming investigation.
